ZyVersa Therapeutics Statistics
Total Valuation
ZVSA has a market cap or net worth of 1.62 million. The enterprise value is 2.51 million.
| Market Cap | 1.62M |
| Enterprise Value | 2.51M |
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ZVSA has 8.10 million shares outstanding. The number of shares has increased by 316.62% in one year.
| Current Share Class | 8.10M |
| Shares Outstanding | 8.10M |
| Shares Change (YoY) | +316.62% |
| Shares Change (QoQ) | -0.58% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 0.00% |
| Float | 7.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.10 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.05
| Current Ratio | 0.05 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.41 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -34.55% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 42.51% |
| Weighted Average Cost of Capital (WACC) | 19.69% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -4.08M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -851,659 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.67% in the last 52 weeks. The beta is 0.79, so ZVSA's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | -66.67% |
| 50-Day Moving Average | 0.20 |
| 200-Day Moving Average | 0.18 |
| Relative Strength Index (RSI) | 51.41 |
| Average Volume (20 Days) | 8,590 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.00M |
| Pretax Income | -25.34M |
| Net Income | -24.49M |
| EBITDA | n/a |
| EBIT | -6.00M |
| Earnings Per Share (EPS) | -3.40 |
Balance Sheet
The company has 302,660 in cash and 1.20 million in debt, with a net cash position of -897,340 or -0.11 per share.
| Cash & Cash Equivalents | 302,660 |
| Total Debt | 1.20M |
| Net Cash | -897,340 |
| Net Cash Per Share | -0.11 |
| Equity (Book Value) | -14.12M |
| Book Value Per Share | -1.74 |
| Working Capital | -14.12M |
Cash Flow
| Operating Cash Flow | -4.14M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 1.00M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ZVSA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -316.62% |
| Shareholder Yield | -316.62% |
| Earnings Yield | -1,513.93% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 26, 2024. It was a reverse split with a ratio of 0.1.
| Last Split Date | Apr 26, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |